Natco Pharma to review financial results and potential dividend at November board meeting Back

<p>Natco Pharma Limited will hold a board meeting on November 13, 2026, to consider the unaudited financial results for the quarter and half year ended September 30, 2026, and to consider the declaration of a second interim dividend for the financial year ending 2026-27. The company also announced that the trading window for its directors, designated persons, and connected persons was closed from October 30, 2026, and will reopen on November 16, 2026, in accordance with SEBI regulations.</p>